The B7 H4 Antibody Market is growing as immuno-oncology research expands and demand increases for antibodies targeting novel immune checkpoints and tumor-associated antigens. Market estimates differ by scope: one forecast places the B7-H4 antibody market at USD 1.2 billion in 2024 with growth to about USD 2.5 billion by 2033 at a 9.2% CAGR, while another research-focused segment valued the...